Javascript must be enabled to continue!
Cryoablation of goiter irrespective of thyroid profile
View through CrossRef
Abstract
Background
Thyroid nodules are extremely common. By age 60, about one-half of all people have a thyroid nodule. Cryoablation is used in a variety of clinical applications, using hollow needles (cryoprobes). Cryoprobes are inserted into or placed adjacent to diseased tissue which is desired to be ablated.
Aim of work
To evaluate the effect of Cryoablation on the size & function of thyroid noduleWhich may replace the need for surgery or radiotherapy.
Patients & methods
This is an interventional therapeutic study, conducted in Ain-Shams University hospitals; endocrinology clinic. Our study sample included 80 subjects, age between 20 & 60, having thyroid nodule diagnosed by ultrasound. Subjects were divided into 2 groups: Group 1 included 40 subjects “control group” who were not subjected to cryoablation. Group 2 included 40 subjects “cases” upon which cryoablation was done. Neck ultrasound was done for subjects & they were sampled for their TSH, free T4 & free T3 levels at start and after 3 & 6 months.
Results
There was high statistical significant difference between group 1 & group 2 regarding nodule size after 6 months. Group 1 showed mean nodule size (0.89 cm ± 0.25 SD) while group 2 showed (0.62 cm ± 0.35 SD),(p-value<0.001). Non-thyrotoxic cases were 6 times more liable to show nodule size reduction, from 0-6 months, more than thyrotoxiccases, which shows thyrotoxicosis as a factor against nodule size reduction in significant statistical relation. Females were more liable than males, to show nodule size reduction. There was no statistical significant difference between cases & controls regarding TSH, free T4 nor free T3 values, before study, at 3 months nor after 6 months.
Conclusions
Cryoablation causes nodule size reduction, especially after 2nd session. Cryoablation doesn’t affect thyroid function tests, all through our study.
Oxford University Press (OUP)
Title: Cryoablation of goiter irrespective of thyroid profile
Description:
Abstract
Background
Thyroid nodules are extremely common.
By age 60, about one-half of all people have a thyroid nodule.
Cryoablation is used in a variety of clinical applications, using hollow needles (cryoprobes).
Cryoprobes are inserted into or placed adjacent to diseased tissue which is desired to be ablated.
Aim of work
To evaluate the effect of Cryoablation on the size & function of thyroid noduleWhich may replace the need for surgery or radiotherapy.
Patients & methods
This is an interventional therapeutic study, conducted in Ain-Shams University hospitals; endocrinology clinic.
Our study sample included 80 subjects, age between 20 & 60, having thyroid nodule diagnosed by ultrasound.
Subjects were divided into 2 groups: Group 1 included 40 subjects “control group” who were not subjected to cryoablation.
Group 2 included 40 subjects “cases” upon which cryoablation was done.
Neck ultrasound was done for subjects & they were sampled for their TSH, free T4 & free T3 levels at start and after 3 & 6 months.
Results
There was high statistical significant difference between group 1 & group 2 regarding nodule size after 6 months.
Group 1 showed mean nodule size (0.
89 cm ± 0.
25 SD) while group 2 showed (0.
62 cm ± 0.
35 SD),(p-value<0.
001).
Non-thyrotoxic cases were 6 times more liable to show nodule size reduction, from 0-6 months, more than thyrotoxiccases, which shows thyrotoxicosis as a factor against nodule size reduction in significant statistical relation.
Females were more liable than males, to show nodule size reduction.
There was no statistical significant difference between cases & controls regarding TSH, free T4 nor free T3 values, before study, at 3 months nor after 6 months.
Conclusions
Cryoablation causes nodule size reduction, especially after 2nd session.
Cryoablation doesn’t affect thyroid function tests, all through our study.
Related Results
Primary Thyroid Non-Hodgkin B-Cell Lymphoma: A Case Series
Primary Thyroid Non-Hodgkin B-Cell Lymphoma: A Case Series
Abstract
Introduction
Non-Hodgkin lymphoma (NHL) of the thyroid, a rare malignancy linked to autoimmune disorders, is poorly understood in terms of its pathogenesis and treatment o...
Thyroid Hemiagenesis: A Single-Center Case Series
Thyroid Hemiagenesis: A Single-Center Case Series
Abstract
Introduction: Thyroid hemiagenesis (TH) is a rare congenital anomaly characterized by the complete absence of one thyroid lobe, with or without absence of the isthmus. Its...
Clinicopathological Features of Indeterminate Thyroid Nodules: A Single-center Cross-sectional Study
Clinicopathological Features of Indeterminate Thyroid Nodules: A Single-center Cross-sectional Study
Abstract
Introduction
Due to indeterminate cytology, Bethesda III is the most controversial category within the Bethesda System for Reporting Thyroid Cytopathology. This study exam...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Unusual Metastasis from Follicular Thyroid Carcinoma: A Case Report and Literature Review
Unusual Metastasis from Follicular Thyroid Carcinoma: A Case Report and Literature Review
Abstract
Introduction
Follicular thyroid carcinoma (FTC) is a type of well-differentiated thyroid carcinoma. It has a poorer prognosis, is more metastatic, and has characteristics ...
Hyalinizing Trabecular Tumor: A Case Series with Literature Review
Hyalinizing Trabecular Tumor: A Case Series with Literature Review
Abstract
Introduction: Hyalinizing trabecular tumor (HTT) is a rare thyroid neoplasm originating from follicular cells and poses diagnostic challenges due to its cytologic and hist...
Data from Cryoablation Does Not Significantly Contribute to Systemic Effector Immune Responses in a Poorly Immunogenic B16F10 Melanoma Model
Data from Cryoablation Does Not Significantly Contribute to Systemic Effector Immune Responses in a Poorly Immunogenic B16F10 Melanoma Model
<div>AbstractPurpose:<p>Cryoablation is a minimally invasive procedure implemented to destroy solid tumors. It also results in the release of tumor antigens into the sy...
Data from Cryoablation Does Not Significantly Contribute to Systemic Effector Immune Responses in a Poorly Immunogenic B16F10 Melanoma Model
Data from Cryoablation Does Not Significantly Contribute to Systemic Effector Immune Responses in a Poorly Immunogenic B16F10 Melanoma Model
<div>AbstractPurpose:<p>Cryoablation is a minimally invasive procedure implemented to destroy solid tumors. It also results in the release of tumor antigens into the sy...

